SCHEMBL31240475

SCHEMBL31240475

CCCNC(=O)Nc1cc(-c2ccc3[nH]nc(N)c3c2)ccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 12/20 0.57
▸ JAK2 O60674 6/20 0.49
▸ KDR P35968 2/20 0.47
▸ PLK4 O00444 2/20 0.47
▸ DAPK3 O43293 2/20 0.47
▸ DYRK3 O43781 2/20 0.47
▸ ROCK2 O75116 2/20 0.47
▸ MAP4K4 O95819 2/20 0.47
▸ CDK1 P06493 2/20 0.47
▸ RPS6KB1 P23443 2/20 0.47
▸ CDK2 P24941 2/20 0.47
▸ MARK3 P27448 2/20 0.47
▸ TYK2 P29597 2/20 0.47
▸ CLK2 P49760 2/20 0.47
▸ JAK3 P52333 2/20 0.47
▸ LIMK1 P53667 2/20 0.47
▸ CDK5 Q00535 2/20 0.47
▸ PRKCD Q05655 2/20 0.47
▸ MAP4K2 Q12851 2/20 0.47
▸ ROCK1 Q13464 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26685737 1.00 MAPK1 (0.57) MAPK1JAK2KDRPLK4DAPK3
SCHEMBL31240315 0.91 MAPK1 (0.56) MAPK1JAK2KDRPLK4DAPK3
SCHEMBL26685764 0.91 MAPK1 (0.56) MAPK1JAK2KDRPLK4DAPK3
SCHEMBL26686173 0.90 MAPK1 (0.56) MAPK1JAK2PLK4DAPK3DYRK3
SCHEMBL30633349 0.90 MAPK1 (0.56) MAPK1JAK2PLK4DAPK3DYRK3
SCHEMBL31240323 0.89 MAPK1 (0.47) MAPK1JAK2DYRK1A
SCHEMBL30633327 0.89 MAPK1 (0.60) MAPK1
SCHEMBL26686009 0.89 MAPK1 (0.47) MAPK1JAK2DYRK1A
SCHEMBL26686017 0.89 MAPK1 (0.60) MAPK1
SCHEMBL30633294 0.88 MAPK1 (0.49) MAPK1JAK2PLK4DAPK3DYRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 — — CN claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 — — CN disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback